Back
ESC Premium Access

Syntax-Score II Based Assessment for role of complete revascularization by using percutaneous coronary intervention among Patients with Chronic Total Occlusion

Session: Poster Session 7 - Risk scores at coronary revascularisation
Topic: Chronic Total Occlusion (CTO)
Speaker: Doctor M. Shiba (Tokyo, JP)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Masanori Shiba

Nissan Tamagawa Hospital, Tokyo (Japan)
0 follower

9 more presentations in this session

Enhanced bedside PCI risk score predicting major adverse cardiovascular events

Speaker: Doctor L. Wang (Singapore, SG)

Access
Abstract
Slides
Like
Thumbnail

Validation of an NCDR-score-based risk model for cardiac catheterization procedures in a european population

Speaker: Doctor M. Brockmeyer (Duesseldorf, DE)

Access
Abstract
Slides
Like
Thumbnail

The ARDVAARC study: real-world outcomes and the utility of bleeding risk scores in patients who require anticoagulation following percutaneous coronary intervention (PCI)

Speaker: Doctor M. Li Kam Wa (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Utility of SYNTAX score II in revascularization decision-making process in patients with acute coronary syndrome without local heart surgery facilities

Speaker: Doctor F. Abcha (Tunis, TN)

Access
Abstract
Slides
Like
Thumbnail

Comparison of residual added index with residual sYNTAX score in the risk stratification of patients with incomplete coronary percutaneous revascularization after ST-elevation myocardial infarction

Speaker: Doctor L. Di Serafino (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 7 - Risk scores at coronary revascularisation

Speakers: Doctor M. Shiba, Doctor L. Wang, Doctor M. Brockmeyer, Doctor M. Li Kam Wa, Doctor F. Abcha...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources